(US) /    Tel: (781) 999-4286 / (781) 999-5354
Home > CDK
Cat.No. Product Name Information Area
T6940 PHA767491 HCl

PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM...

T4417 LDC-4297 HCl (1453834-21-3(free base)) LDC4297 is a potent and selective CDK7 inhibitor with an IC50 of 0.13 nM.
T4293 THZ531 THZ531 is a covalent inhibitor of both CDK12(IC50=158 nM) and CDK13(IC50=69 nM). cancer
T4227 SB1317(TG-02) hydrochloride (937270-47-8(free base))

SB1317 is an effective inhibitor of CDK2/JAK2/FLT3 (IC50: 13/73/56 nM).

T4051 LDC4297 LDC4297 is a potent and selective CDK7 inhibitor. Others
T3589 NSC23005 Sodium NSC23005 sodium is a novel and effective p18 inhibitor (ED50=5.21 nM) in promoting He... Others
T3186 NU2058 NU2058 is a guanine-based CDK inhibitor, also inhibits DNA topoisomerase II ATPase ac... Cancer
T3664 THZ1 THZ1 is a novel selective and potent covalent CDK7 inhibitor. Cancer
T6924 P276-00 P276-00 is a novel CDK1, CDK4 and CDK9 inhibitor with IC50 of 79 nM, 63 nM and 20 nM,... Others
T6920 ON123300 ON123300 is a potent and multi-targeted kinase inhibitor for CDK4/Ark5/PDGFRβ/FGFR1/R... Others
T6866 K03861 K03861 is a type II CDK2 inhibitor with Kd of 50 nM, 18.6 nM, 15.4 nM, and 9.7 nM for... Others
T6837 Flavopiridol (Alvocidib) Flavopiridol (Alvocidib) competes with ATP to inhibit CDKs including CDK1, CDK2, CDK4... Others
T3207 Briciclib Briciclib is a small molecule that suppresses cyclin D1 accumulation in Y cells. Other
T3195 CVT-313 CVT-313(NG-26) is a potent, selective, reversible, and ATP-competitive inhibitor. Cancer
T6735 XL413-hydrochloride XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibito... Cancer
T6612 NU6027 NU6027 is a potent ATR/CDK inhibitor, inhibits CDK1/2, ATR and DNA-PK with Ki of 2.5 ... Cancer
T6563 LDC000067 LDC000067 is a highly specific and selective CDK9 inhibitor with an IC50 value of 44±... Cancer
T6240 Palbociclib (PD0332991) Isethionate Palbociclib (PD0332991) Isethionate is a highly specific CDK4/6 inhibitor ( IC50: 11/... Cancer
T6239 Palbociclib (PD-0332991) hydrochloridehot Palbociclib (PD-0332991) HCl, a greatly selective inhibitor of CDK4/6, with IC50 for ...
T6206 PHA-767491 PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM an... cancer
T6205 AT7519 AT7519 is a CDK1/2/4/6/9 inhibitor (IC50: 10-210 nM). It is less effective to CDK3 an... Cancer
T6199 LEE011 LEE011 is an orally available, and highly specific CDK4/6 inhibitor (IC50:10/39 nM). Cancer
T6167 SU9516 SU9516 is a potent CDK2 inhibitor, with an IC50 of 22 nM, and also has inhibitory eff... Cancer
T6162 BS-181 hydrochloride BS-181 HCl is a highly selective CDK7 inhibitor with IC50 of 21 nM. It is more than 4... Cancer
T6126 JNJ-7706621 JNJ-7706621 is a potent aurora kinase inhibitor, and also inhibits CDK1 and CDK2. Cancer
T6081 Milciclib (PHA-848125) Milciclib (PHA-848125) is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 ... Cancer
T6049 SNS-032 (BMS-387032) SNS-032 is a selective inhibitor of CDK2 (IC50: 48 nM ) and is 10- and 20-fold select... Cancer
T3111 LY2835219 LY2835219 is a specific and effective inhibitor of CDK4(IC50=2 nM) and CDK6(IC50=10 n... Cancer
T2679 BMS-265246 BMS-265246 is a potent and selective CDK1/2 inhibitor. Cancer
T2670 ML167 ML167 is a highly selective Cdc2-like kinase 4 (Clk4) inhibitor. Cancer